Want to join the conversation?
Biotechnology company $TMO signed an agreement in January 2016 to acquire Affymetrix, Inc. for approx. $1.3Bil in cash. The transaction is expected to close by the end of 2Q16, subject to conditions and approvals. The company expects to issue debt in advance of closing the acquisition of Affymetrix to partially fund the acquisition.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.